Cellomatics Biosciences Wins Queen’s Award for EnterpriseGemma Cann2022-07-13T11:58:15+01:00April 21st, 2022|BioCity Nottingham, News|
Upperton Pharma Solutions Launches Nasal Delivery Development PlatformGemma Cann2022-06-30T11:32:23+01:00April 14th, 2022|News|
Life Science Start-Up Report 2022 Launched by Pioneer Group and JLLGemma Cann2023-07-24T14:00:56+01:00April 11th, 2022|Accelerator, Article, Investment, News|
AbbVie Partners with Pioneer Group to Launch the Golden Ticket ProgrammeGemma Cann2023-09-04T12:31:42+01:00April 6th, 2022|Accelerator, Article, Investment, News|
Invizius Awarded Major Biomedical Catalyst GrantGemma Cann2022-06-30T11:33:29+01:00April 1st, 2022|BioCity Glasgow, News|
Absolute Antibody Licenses Novel Fc Silencing Technology from mAbsolveGemma Cann2022-06-30T11:33:55+01:00March 31st, 2022|News, Wilton Centre|
Platelet Services Appoints Senior Research Scientist to Support GrowthGemma Cann2022-06-30T11:34:19+01:00March 30th, 2022|BioCity Nottingham, News|
4Degra Finalist for TCT Materials AwardGemma Cann2022-06-30T11:34:59+01:00March 29th, 2022|MediCity Nottingham, News|
GW Pharmaceuticals Begins Construction on 60,000sq ft Cannabis Facility at Kent Science ParkGemma Cann2022-06-30T11:38:39+01:00March 25th, 2022|Kent Science Park, News|
Cellomatics Strengthens Senior Management Team with Key AppointmentGemma Cann2022-06-30T11:39:44+01:00March 22nd, 2022|News|
